Estramustine

From Wikipedia, the free encyclopedia

Estramustine
Systematic (IUPAC) name
(17-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17- decahydro-6H-cyclopenta[a]phenanthren-3-yl) bis (2-chloroethyl)aminomethanoate
Identifiers
CAS number 2998-57-4
ATC code L01XX11
PubChem 18140
DrugBank APRD00625
Chemical data
Formula C23H31Cl2NO3 
Mol. mass 440.403 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life 20 hours
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Estramustine (Emcyt) is a chemotherapy agent used to treat prostate cancer. It is a derivative of estrogen (specifically, estradiol) with an nitrogen mustard-carbamate ester moiety that makes it a alkylating antineoplastic agent similar to mechlorethamine, with estrogen-induced specificity.

Estramustine is marketed in the United States by Pharmacia (now a subsidiary of Pfizer)

[edit] Clinical uses

Estramustine is indicated for the palliative treatment of metastatic and/or progressive carcinoma of the prostate.

[edit] External links

Languages